Mounjaro vs Saxenda: Weekly vs Daily Weight Loss Injections

Comparing Mounjaro (tirzepatide) and Saxenda (liraglutide)—the newer powerhouse versus the established option. Which offers better results, and is the daily injection commitment worth it?

🔬 Two Generations of GLP-1 Therapy

Saxenda was revolutionary when it launched in 2015 as the first GLP-1 medication specifically for weight loss. Mounjaro represents the next evolution—more powerful, more convenient, but also newer with less long-term data.

Introduction – Two GLP-1 Options for Weight Loss

Saxenda (liraglutide 3mg) and Mounjaro (tirzepatide) both belong to the GLP-1 receptor agonist family of medications—drugs that mimic gut hormones to suppress appetite and aid weight loss. But they represent different generations of this technology, with distinct advantages and trade-offs.

Saxenda has been available in the UK since 2015, giving it nearly a decade of real-world use and safety data. It was groundbreaking at the time, offering 5-10% average weight loss when diet and exercise alone often failed.

Mounjaro arrived in 2022 with a novel dual-action mechanism and dramatically superior results—doubling or even tripling Saxenda's weight loss in trials. However, it's newer, with less long-term data, and comes at a slightly higher cost.

This comparison will help you understand which might be right for you, covering effectiveness, convenience, side effects, and access in the UK.

🩷

Saxenda

Liraglutide 3mg
Daily GLP-1 injection

APPROVED
2015 (UK)
DOSING
Once daily injection
AVERAGE WEIGHT LOSS
5-10% body weight
INJECTIONS PER YEAR
365
MECHANISM
GLP-1 only
💜

Mounjaro

Tirzepatide
Weekly dual-action injection

APPROVED
2022 (UK)
DOSING
Once weekly injection
AVERAGE WEIGHT LOSS
15-22% body weight
INJECTIONS PER YEAR
52
MECHANISM
GLP-1 + GIP dual agonist

Mechanisms and Dosing: Daily vs Weekly

How Saxenda Works

Saxenda mimics GLP-1, a hormone your gut naturally releases after eating. It:

  • Reduces appetite by acting on hunger centres in the brain
  • Slows how quickly your stomach empties, keeping you fuller longer
  • Helps regulate blood sugar by improving insulin release

Dosing schedule: You inject Saxenda subcutaneously (under the skin) every single day, typically at the same time. You start at 0.6mg and gradually increase over 5 weeks to the full 3mg dose. The pen is multi-dose, lasting about 6 days before you need a new one.

How Mounjaro Works

Mounjaro activates both GLP-1 and GIP receptors:

  • All the same GLP-1 benefits as Saxenda (appetite suppression, slower digestion, better insulin function)
  • Plus GIP activation: Enhances insulin sensitivity, may improve fat metabolism, and works synergistically with GLP-1 for greater effect

Dosing schedule: Once weekly injection. You start at 2.5mg and increase monthly (if tolerated) up to 5mg, 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose. Each pen is single-use.

📅 Injection Frequency Visual

One week of treatment:

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Saxenda (Daily):

💉
💉
💉
💉
💉
💉
💉

Mounjaro (Weekly):

💉
Saxenda: 7 injections/week = 365/year
Mounjaro: 1 injection/week = 52/year

💡 Convenience factor: The difference is stark—Saxenda requires 365 injections per year versus Mounjaro's 52. For many people, the once-weekly convenience of Mounjaro is a major advantage, reducing injection fatigue and improving adherence.

Efficacy – How Much Weight Can You Lose?

This is where Mounjaro pulls significantly ahead:

Average Weight Loss Comparison

Mounjaro
20-22% (high dose)
Saxenda
5-10%

Clinical Trial Results

Saxenda (SCALE trials):

  • Average weight loss: 5-8% of body weight over 56 weeks
  • About 63% of participants lost ≥5% of their weight
  • About 33% lost ≥10%
  • For a 100kg person: typical loss of 5-8kg (0.8-1.3 stone)

Mounjaro (SURMOUNT trials):

  • Average weight loss: 15-22.5% depending on dose (72 weeks)
  • 89% of participants on 15mg lost ≥5%
  • 57% lost ≥20%
  • For a 100kg person: typical loss of 15-22.5kg (2.4-3.5 stone)

📊 The math: Mounjaro delivers roughly 2-4x more weight loss than Saxenda on average. This represents the difference between modest improvement and truly life-changing results for many people.

Side Effects Comparison

Both medications cause similar gastrointestinal side effects, as they both work on the GLP-1 system:

Side Effect Mounjaro Saxenda
Nausea 20-30% 40-50%
Diarrhoea 12-18% 20-25%
Constipation 10-15% 20-25%
Vomiting 8-12% 15-18%
Injection site reactions Rare Slightly more common (daily injections)
Headache Moderate Moderate-common

Notable Differences

  • Saxenda tends to cause higher rates of GI side effects, particularly nausea and constipation—possibly because it's dosed daily, giving less "break" between doses
  • Daily dosing with Saxenda might mean more consistent mild nausea, whereas Mounjaro's weekly dosing might cause periodic stronger nausea for 1-2 days post-injection
  • Injection site issues (redness, bruising) are slightly more common with Saxenda simply due to injecting 7x more often
  • Both improve over time as your body adjusts, typically within 4-8 weeks

⚠️ Serious side effects (rare, both drugs): Pancreatitis, gallbladder disease, kidney problems, increased heart rate, and theoretical thyroid tumour risk (seen in rodents, not confirmed in humans). Both are contraindicated with personal/family history of medullary thyroid cancer or MEN2.

Cost and Accessibility

NHS Access

Saxenda:

  • Can be prescribed on the NHS for obesity (BMI ≥35 with comorbidity or ≥40)
  • Availability varies by region—some ICBs restrict it heavily due to cost
  • Often requires specialist referral to tier 3 weight management service
  • Not as widely available as it once was, with NHS shifting focus to newer, more effective options

Mounjaro:

  • NICE-approved for NHS obesity use (December 2025), with phased rollout starting
  • Similar eligibility: BMI ≥35 with comorbidity or ≥40
  • Prioritised over Saxenda in many areas due to superior efficacy
  • Limited availability initially, expanding through 2025

Private Costs

Treatment Phase Mounjaro (Monthly) Saxenda (Monthly)
Starting dose £170-£210 £160-£200
Maintenance dose £250-£350 £180-£230
12-month cost £2,800-£3,600 £2,000-£2,600

Cost comparison: Saxenda is roughly £600-1,000 cheaper per year privately. However, given Mounjaro delivers 2-4x the weight loss, many consider it better value for money—you're paying slightly more for dramatically better results.

Who Might Choose Which?

✓ Choose Mounjaro if:

  • You want maximum weight loss results
  • Once-weekly convenience appeals to you
  • You're new to weight loss injections
  • You can access it (NHS or afford private)
  • You have type 2 diabetes alongside obesity
  • You want the newest, most effective option

→ Choose Saxenda if:

  • You prefer a medication with longer real-world safety data (10 years vs 3)
  • You're on a tighter budget and Saxenda is significantly cheaper for you
  • You prefer daily dosing for steadier, more consistent effects
  • You've already tried Saxenda and it worked well
  • Your doctor recommends starting with an established option first
  • Mounjaro is unavailable or unsuitable for you

Switching from Saxenda to Mounjaro

Many people have successfully transitioned from Saxenda to Mounjaro seeking better results. If you've been on Saxenda and are considering switching:

  • Discuss with your prescribing doctor—they'll determine an appropriate Mounjaro starting dose (likely higher than 2.5mg if you're already tolerating Saxenda 3mg)
  • Expect a transition period where side effects may temporarily increase
  • You should see enhanced weight loss within 2-3 months if Mounjaro works well for you

🔍 Compare Both Options

See current UK pricing for Mounjaro and Saxenda from trusted providers

View Prices & Providers

Frequently Asked Questions

What's the difference between Saxenda and Mounjaro?

Saxenda (liraglutide) is a daily GLP-1 injection approved in 2015, delivering 5-10% average weight loss. Mounjaro (tirzepatide) is a weekly dual GLP-1/GIP injection approved in 2022, delivering 20-22% average weight loss. Mounjaro is more convenient (weekly vs daily) and significantly more effective.

Is Mounjaro better than Saxenda for weight loss?

Yes, Mounjaro typically delivers 2-4x more weight loss than Saxenda in clinical trials. Mounjaro users lose 15-22% of body weight on average vs Saxenda's 5-10%. Mounjaro also requires only weekly injections vs Saxenda's daily requirement, making it more convenient.

Why would someone choose Saxenda over Mounjaro?

Saxenda has been available longer (since 2015) with more long-term safety data. Some may prefer daily dosing for steadier effects, or their doctor may recommend starting with Saxenda as an older, more established medication. Cost can also be a factor—Saxenda is roughly £600-1,000 cheaper per year privately, though Mounjaro's superior results often justify the difference.

Do I have to inject Saxenda every single day?

Yes, Saxenda must be injected once daily, ideally at the same time each day. Missing doses reduces effectiveness. This daily commitment is a major reason many people prefer weekly options like Mounjaro or Wegovy. That said, many Saxenda users adapt to the routine and find it manageable.

Can I switch from Saxenda to Mounjaro?

Yes, many people successfully switch. Your doctor will guide the transition, likely starting you on a mid-range Mounjaro dose (e.g., 5mg or 7.5mg) rather than the 2.5mg starter, since you're already tolerating Saxenda's GLP-1 effects. There may be a temporary increase in side effects as you adjust.

Which has worse side effects?

Saxenda generally has higher reported rates of nausea (40-50% vs 20-30% for Mounjaro) and GI issues, possibly due to daily dosing. However, individual experiences vary. Some people tolerate Saxenda perfectly well, whilst others find Mounjaro's weekly dosing easier on the stomach. Both cause similar types of side effects (nausea, diarrhoea, constipation) that typically improve over time.

The Bottom Line

Saxenda was revolutionary when it launched, offering hope to millions struggling with obesity. It remains a perfectly valid option with a strong safety record and proven effectiveness.

However, Mounjaro represents a clear advancement in weight loss pharmacotherapy. Its dual mechanism delivers superior results—often double or triple Saxenda's weight loss—with the added convenience of weekly rather than daily injections.

For most people starting a weight loss medication today, Mounjaro is the better choice if accessible and affordable. The significantly greater weight loss and improved convenience justify the marginal extra cost for those who can manage it.

That said, Saxenda still has a place: for those who prefer an established medication with longer-term data, who respond well to it, or who find it more accessible via the NHS or affordably through private providers.

Whichever you choose, remember that medication is just one tool. Combining it with healthy eating, regular activity, good sleep, and stress management will maximise your results and help maintain your weight loss long-term.

Find the Right Option for You

Compare prices and access options for both Mounjaro and Saxenda from verified UK providers

Start Your Comparison

⚠️ Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Both Mounjaro and Saxenda are prescription-only medications in the UK. Always consult with a qualified healthcare professional before starting any weight loss treatment. Individual results vary. This content has not been evaluated by the MHRA.

⬆️
Latest Updates

Recent News About Related Topics

This guide is regularly reviewed. Here's what's changed recently in the UK: